Eloxx Pharmaceuticals, Inc. (ELOX)

US · Healthcare · Biotechnology

$17.55-0.45%

Last close · 2026-09-17

Key statistics

Market cap

$55.9M

P/E

4.8

Forward P/E

0.0

P/B

1.23

Book value

$11.50

EPS (TTM)

$3.39

52-week high

$23.40

52-week low

$8.20

50-day MA

$15.18

200-day MA

$14.63

Beta

-162,178.47

with an average price target of $40.33.

Insiders

26.28%

Institutions

81.08%

Fund	Stake
EcoR1 Capital, LLC	11.64%
Samsara BioCapital, LLC	11.64%
Aberdeen Group PLC	11.64%
SEVEN GRAND MANAGERS, LLC	0.29%
Pioneer Family Office, LLC	0.00%
OLD POINT TRUST & FINANCIAL SERVICES N A	0.00%
Activest Wealth Management	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Eloxx Pharmaceuticals, Inc. — free to start.

Data updated 2026-09-18.